The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
A Direct Effect of Hyperinsulinemia on Serum Sex Hormone-Binding Globulin Levels in Obese Women with the Polycystic Ovary Syndrome*
Abstract
To determine whether hyperinsulinemia can directly reduce serum sex hormone-binding globulin (SHBG) levels in obese women with the polycystic ovary syndrome, six obese women with this disorder were studied. Before study, ovarian steroid production was suppressed in each woman by the administration of 7.5 mg of a long-acting GnRH agonist, leuprolide depot, im, on days -56, -28, and 0. This resulted in substantial reductions in serum concentrations of testosterone (from 1.72 +/- 0.29 nmol/L on day -56 to 0.32 +/- 0.09 nmol/L on day 0), non-SHBG-bound testosterone (from 104 +/- 16 pmol/L on day -56 to 19 +/- 5 pmol/L on day 0), androstenedione (from 7.25 +/- 1.65 nmol/L on day -56 to 2.78 +/- 0.94 nmol/L on day 0), estrone (from 371 +/- 71 pmol/L on day -56 to 156 +/- 29 pmol/L on day 0), estradiol (from 235 +/- 26 pmol/L on day -56 to 90 +/- 24 pmol/L on day 0), and progesterone (from 0.28 +/- 0.12 nmol/L on day -56 to 0.08 +/- 0.02 nmol/L on day 0). Serum SHBG levels, however, did not change (18.8 +/- 2.8 nmol/L on day -56 vs. 17.8 +/- 2.6 nmol/L on day 0). While continuing leuprolide treatment, the women were administered oral diazoxide (300 mg/day) for 10 days to suppress serum insulin levels. Diazoxide treatment resulted in suppressed insulin release during a 100-g oral glucose tolerance test (insulin area under the curve, 262 +/- 55 nmol/min.L on day 0 vs. 102 +/- 33 nmol/min.L on day 10; P less than 0.05) and deterioration of glucose tolerance. Serum testosterone, androstenedione, estrone, estradiol, and progesterone levels did not change during combined diazoxide and leuprolide treatment. In contrast, serum SHBG levels rose by 32% from 17.8 +/- 2.6 nmol/L on day 0 to 23.5 +/- 2.0 nmol/L on day 10 (P less than 0.003). Due primarily to the rise in serum SHBG levels, serum non-SHBG-bound testosterone levels fell by 43% from 19 +/- 5 pmol/L on day 0 to 11 +/- 4 pmol/L on day 10 (P = 0.05). These observations suggest that hyperinsulinemia directly reduces serum SHBG levels in obese women with the polycystic ovary syndrome independently of any effect on serum sex steroids.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Hyperinsulinaemia also plays an indirect role in hyperandrogenism by inhibiting hepatic sex hormone-binding globulin (SHBG) production, thus increasing free testosterone (Kiddy et al., 1989;Nestler et al., 1991).”
From Insulin resistance in polycystic ovary syndrome: a systematic review and meta-analysis of euglycaemic–hyperinsulinaemic clamp studies (2016) · cites this paper as Nestler et al., 1991
In the citing paper
“The result of IR is hyperinsulinemia, which has a central role in the pathogenesis of androgen excess in PCOS.”
From From Prediabetes to Type 2 Diabetes Mellitus in Women with Polycystic Ovary Syndrome: Lifestyle and Pharmacological Management (2020) · cites this paper as [6]
Citations
Cites
Morgan, C. R., & Lazarow, A. (1963) · Diabetes · doi:10.2337/diab.12.2.115 · Cited by 2,197
Profound Peripheral Insulin Resistance, Independent of Obesity, in Polycystic Ovary Syndrome
Dunaif, A., Segal, K. R., Futterweit, W., & Dobrjansky, A. (1989) · Diabetes · doi:10.2337/diab.38.9.1165 · Cited by 1,967
Correlation of Hyperandrogenism with Hyperinsulinism in Polycystic Ovarian Disease*
Burghen, G. A., Givens, J. R., & Kitabchi, A. E. (1980) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-50-1-113 · Cited by 919
Insulin resistance in nonobese patients with polycystic ovarian disease
CHANG, R. J., NAKAMURA, R. M., JUDD, H. L., & KAPLAN, S. A. (1983) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-57-2-356 · Cited by 704
REVIEW ARTICLE: THE POLYCYSTIC OVARY SYNDROME
Yen, S. S. C. (1980) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1980.tb02132.x · Cited by 697
PLYMATE, S. R., MATEJ, L. A., JONES, R. E., & FRIEDL, K. E. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-67-3-460 · Cited by 693
Self-citationBarbieri, R. L., Makris, A., Randall, R. W., Daniels, G. H., Kistner, R. W., & Ryan, K. J. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-62-5-904 · Cited by 629
NESTLER, J. E., BARLASCINI, C. O., CLORE, J. N., & BLACKARD, W. G. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-66-1-57 · Cited by 414
Self-citationKIDDY, D. S., SHARP, P. S., WHITE, D. M., SCANLON, M. F., MASON, H. D., BRAY, C. S., POLSON, D. W., REED, M. J., & FRANKS, S. (1990) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1990.tb00857.x · Cited by 364
Circulating gonadotropins, estrogens, and androgens in polycystic ovarian disease
DeVane, G. W., Czekala, N. M., Judd, H. L., & Yen, S. S. C. (1975) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(75)90081-2 · Cited by 338
Flagged first, then by citations
Cited by
Sorted by citations
Items 601–700 of 814
Nsr-Allah, A. A.-E. M., El-Fatah, A. H. A., & Ahmed, H. S. (2019) · The Journal of Gene Medicine · doi:10.1002/jgm.3076 · Cited by 4
Physical Activity and Anthropometric Factors
Henderson, K. D., Prescott, J., & Bernstein, L. (2009) · Springer eBooks · doi:10.1007/978-1-4419-0685-4_7 · Cited by 4
Advances in the treatment of polycystic ovary syndrome
Moghetti, P. (2001) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.10.9.1631 · Cited by 4
Yumuk, V., & Yumuk, P. F. (2005) · Indoor and Built Environment · doi:10.1177/1420326x04059284 · Cited by 4
Ayuk, P. T.-Y., Stringfellow, H. F., Donnai, P., Beardwell, C. G., Holt, A., & Laing, I. (1998) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/000456329803500123 · Cited by 4
Xu, L., Min, M., Li, X., Blake, G. M., Zhao, K., Ruan, X., & Cheng, X. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1168806 · Cited by 3
Role of hyperinsulinemic insulin resistance in polycystic ovary syndrome
Iuorno, M. J. (2001) · Polycystic Ovary Syndrome · doi:10.1017/cbo9780511545191.013 · Cited by 3
Gu, R., & Syed, N. (2023) · Undergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal · doi:10.26685/urncst.417 · Cited by 3
Lipohyperplasia dolorosa und Adipositas
Faerber, G. (2023) · Springer eBooks · doi:10.1007/978-3-662-61452-5_24 · Cited by 3
Jia, L. (2006) · Journal of Chinese Integrative Medicine · doi:10.3736/jcim20060608 · Cited by 3
Kar, P., & Cummings, M. (2005) · Practical Diabetes · doi:10.1002/pdi.836 · Cited by 3
Therapy for polycystic ovarian syndrome
WEI, A., & Pritts, E. A. (2003) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2003.06.004 · Cited by 3
Hara, S., Takahashi, T., Igarashi, H., Amita, M., Matsuo, K., Hasegawa, A., & Kurachi, H. (2014) · Journal of Mammalian Ova Research · doi:10.1274/jmor.31.2 · Cited by 3
AlRuthia, Y. S., Al-Mandeel, H. M., Alsanawi, H. A., Balkhi, B. S., Mansy, W., Algasem, R., & Almutairi, L. (2017) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2017.02.008 · Cited by 3
(2012) · InTech eBooks · doi:10.5772/1279 · Cited by 3
Clinical Manifestations of Insulin Resistance in Youth
Chen, M. E., & Hannon, T. (2019) · Contemporary endocrinology · doi:10.1007/978-3-030-25057-7_1 · Cited by 2
Hiperandrogenismo en la mujer diabética: rol de la resistencia insulínica y de la hiperinsulinemia
Tejada, G. G.-R. D., & Escobar-Morreale, H. F. (2003) · Endocrinología y Nutrición · doi:10.1016/s1575-0922(03)74555-0 · Cited by 3
New routes in the polycystic ovary syndrome labyrinth: A way out?
Moghetti, P., & Castello, R. (1998) · Journal of Endocrinological Investigation · doi:10.1007/bf03350793 · Cited by 3
Sümer, F., Gürlek, B., Yıldız, E., Uzun, F., & Çolak, S. (2025) · Scientific Reports · doi:10.1038/s41598-025-94890-6 · Cited by 2
Shetty, S., Karunakara, M. B., Kristipati, R. R., Kalthur, G., & Kumari, S. (2025) · F1000Research · doi:10.12688/f1000research.167998.1 · Cited by 2
The pediatric origins of polycystic ovary syndrome
Roldán, B., & Escobar-Morreale, H. F. (2001) · Cambridge University Press eBooks · doi:10.1017/cbo9780511545191.015 · Cited by 2
Ding, M., Liu, Y., Yang, Y., Ye, Y., Li, L., Huang, J., Chen, X., Yang, D., & Zhao, X. (2021) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2020.0071 · Cited by 2
Optimizing Ovarian Stimulation for IVF in PCOS Patients: A Novel Day 1 GnRH Antagonist Protocol
Dastidar, S. G., Dastidar, B. G., Chattopadhyay, R., & Chakraborty, C. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14165901 · Cited by 2
Haq, M. E. U., Akash, M. S. H., Rehman, K., & Khurshid, M. (2020) · Turkish Journal of Biochemistry · doi:10.1515/tjb-2019-0318 · Cited by 2
Legro, R. S. (2007) · Springer eBooks · doi:10.1007/978-0-387-69248-7_2 · Cited by 2
Polycystic Ovary Syndrome and Its Metabolic Complications
Liao, E. P., & Poretsky, L. (2006) · Humana Press eBooks · doi:10.1007/978-1-59259-985-1_15 · Cited by 2
The association between sex hormone-binding globulin and type 2 diabetes in Nigerian men
Abbiyesuku, F. M., Agbakwuru, A. N., & Olawale, O. O. (2013) · African Journal of Laboratory Medicine · doi:10.4102/ajlm.v2i1.44 · Cited by 2
Markatseli, A. E., Hatzi, E. G., Pamporaki, C., Bouba, I., Xita, N. V., Tigas, S. K., Georgiou, I. A., & Tsatsoulis, A. A. (2014) · Maturitas · doi:10.1016/j.maturitas.2014.03.009 · Cited by 2
Reappraisal of the use of clomifene for ovulation induction
Bekhit, M., & Greenwood, P. (2005) · The Obstetrician & Gynaecologist · doi:10.1576/toag.7.1.014.27037 · Cited by 2
Takahashi, T., Igarashi, H., Hara, S., Amita, M., Matsuo, K., Hasegawa, A., & Kurachi, H. (2014) · Journal of Ovarian Research · doi:10.1186/1757-2215-7-74 · Cited by 2
STUDY OF OVARIAN MORPHOLOGY IN HIGH FRUCTOSE FED MICE
Ekambaram, G. (2014) · Journal of Biomedical and Pharmaceutical Research · Cited by 2
Developmental Programming of Polycystic Ovary Syndrome: Role of Prenatal Androgen Excess
Tsatsoulis, A. A. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-250-6_5 · Cited by 2
Obesity, Type 2 Diabetes and Cancer
Ferguson, R. D., & LeRoith, D. (2011) · Springer eBooks · doi:10.1007/978-1-4614-0598-6_3 · Cited by 2
Qué hay de nuevo en el síndrome de ovario poliquístico
de Guevara, A. L., Nataly Vantman, L., Echiburú, B., Daniel Miranda, S., & Petermann, L. T. S. (2013) · Universidad de Chile · Cited by 2
Coughlan, C., & Ledger, W. J. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511762390.013 · Cited by 2
Effect of Oestrogen Exposure, Obesity, Exercise and Diet on Breast Cancer Risk
Petridou, E. T., Georgakis, M. K., & Antonopoulos, C. N. (2017) · Springer eBooks · doi:10.1007/978-3-319-56673-3_4 · Cited by 2
Das polyzystische Ovarsyndrom: Prototyp eines kardiometabolischen Syndroms
Heutling, D., Schulz, H., Randeva, H. S., Dodt, C., & Lehnert, H. (2007) · Der Internist · Cited by 2
The multifarious role of insulin in PCOS: From pathophysiology to therapeutic management
Moghetti, P. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823045-9.00002-x · Cited by 2
Christou, M., Mintziori, G., Goulis, D. G., & Tarlatzis, B. C. (2023) · ISGE series · doi:10.1007/978-3-031-22378-5_8 · Cited by 2
Johnston-MacAnanny, E. B., Park, J. K., & Berga, S. L. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6837-0_8 · Cited by 2
Obesity and Disease: Hormones and Obesity
Pinkney, J. H. (2005) · Wiley eBooks · doi:10.1002/9780470987087.ch14 · Cited by 2
L’ovaire de l’insulinorésistance
Belaïsch, J., Allart, J. P., & Nahmanovici, C. (2001) · Gynécologie Obstétrique & Fertilité · doi:10.1016/s1297-9589(01)00211-9 · Cited by 2
Tratamiento del síndrome del ovario poliquístico con sensibilizantes a la insulina y antiandrógenos
Moghetti, P. (2006) · Endocrinología y Nutrición · doi:10.1016/s1575-0922(06)71169-x · Cited by 2
Curi, D. D. G. (2007) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2007.tde-04102007-121316 · Cited by 2
Metformin and FSH for induction of ovulation in women with polycystic ovarian syndrome
Leo, V. D. (2002) · Human Reproduction · doi:10.1093/humrep/17.9.2481 · Cited by 2
Mendpara, V. A., Ganampet, N. R., Afroze, S., Gnanasekaran, S., Sahu, S., Atikah, R., Rajpal, S., Raghavan, P., Ajith, K., Parmar, M. P., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-3360467/v1 · Cited by 2
Selvaraj, R. K., Jeyabalan, S., Vasu, S., Palaniyappan, V., & Settu, S. (2021) · INDIAN DRUGS · doi:10.53879/id.58.07.11836 · Cited by 1
Polycystic Ovary Syndrome: Ovulation Induction Strategies
Taha, L. E., Rizk, B. R., Ledger, W. J., Sayegh, R. A., & Awwad, J. T. (2022) · Cambridge University Press eBooks · doi:10.1017/9781316477021.016 · Cited by 1
Tosi, F., Zanolin, M. E., Garofalo, S., Gremes, V., Zoppini, G., & Moghetti, P. (2026) · Journal of Endocrinological Investigation · doi:10.1007/s40618-025-02800-4 · Cited by 1
Clinical presentation of PCOS following development of an insulinoma
Murray, R., Davison, R. M., Russell, R. C. G., & Conway, G. S. (2000) · UCL Discovery (University College London) · Cited by 1
Taponen, S. (2004) · Cited by 1
Aboelnaga, M. M., & Elshahawy, H. A. (2016) · International Journal of Reproduction Contraception Obstetrics and Gynecology · doi:10.18203/2320-1770.ijrcog20162623 · Cited by 1
ÜNLÜTÜRK, E. R. (2008) · Ankara Üniversitesi Tıp Fakültesi Mecmuası · doi:10.1501/tipfak_0000000652 · Cited by 1
Popova, P., Baranova, E. V., & Grineva, E. N. (2009) · Arterial’naya Gipertenziya (Arterial Hypertension) · doi:10.18705/1607-419x-2009-15-2-218-222 · Cited by 1
Recent Updates in Female Pelvic Ultrasound
Liau, J., & Schultz, H. (2020) · Current Radiology Reports · doi:10.1007/s40134-020-00353-3 · Cited by 1
An Insight on Polycystic Ovary Syndrome (PCOS) and Use of Herbal Medicines as Alternative Treatment
Rao, S. K. (2020) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/978-1-7998-4808-0.ch006 · Cited by 1
Wet-cupping on calf muscles in polycystic ovary syndrome: a quasi-experimental study
Meyari, A., Tansaz, M., Tehrani, F. R., Mokaberinejad, R., Biglarkhani, M., Yarandi, R. B., & Fayaz, M. (2021) · Journal of Complementary and Integrative Medicine · doi:10.1515/jcim-2020-0458 · Cited by 1
Use of Insulin Sensitizers in the Polycystic Ovary Syndrome
Cheang, K. I., & Nestler, J. E. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-179-6_38 · Cited by 1
Self-citationStracquadanio, M., & Ciotta, L. (2015) · Springer eBooks · doi:10.1007/978-3-319-16760-2_3 · Cited by 1
Insulin Resistance and Lipotoxicity in PCOS: Causes and Consequences
Carreau, A., Battista, M., & Baillargeon, J. (2022) · Springer eBooks · doi:10.1007/978-3-030-92589-5_8 · Cited by 1
Assessment of Early Markers of Cardiovascular Risk in Polycystic Ovary Syndrome
Alexandraki, K., Eleitho Practice, A., Kandaraki, E., Poulia, K., Piperi, C., Papadimitriou, E., & Papaioannou, T. (2021) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2021.1.1.37 · Cited by 1
Roozbeh, J., Janfeshan, S., Afshari, A., Doostkam, A., & Yaghobi, R. (2022) · PubMed Central · doi:10.22088/ijmcm.bums.11.2.168 · Cited by 1
Pan, M., Zhang, J., Zhang, Q., Wang, F., Qu, F., & Jin, M. (2023) · Clinical and Experimental Obstetrics & Gynecology · doi:10.31083/j.ceog5008162 · Cited by 1
Genetics and Epigenetics of Polycystic Ovary Syndrome
Ponnam, S. P. G., & Paul, A. (2023) · Obstetrics and gynecology. · doi:10.5772/intechopen.113187 · Cited by 1
Ochsner, H., Saner, F. A. M., Flück, C. E., Atlas, G., Wüest, A., Zacharin, M., & Saner, C. C. S. (2024) · Hormone Research in Paediatrics · doi:10.1159/000539697 · Cited by 1
Polycystic Ovary Syndrome and Metabolic Syndrome
Pesant, M.-H., & Baillargeon, J. (2009) · Humana Press eBooks · doi:10.1007/978-1-59745-192-5_14 · Cited by 1
Stracquadanio, M. (2019) · Springer eBooks · doi:10.1007/978-3-030-29223-2_2 · Cited by 1
Androgens and Cardiovascular Risk Factors in Polycystic Ovary Syndrome
Cardozo, L. L. Y., Huffman, A. M., Pruett, J. E., & Romero, D. G. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.96005 · Cited by 1
Challenges in Establishing a Relevant Model of Polycystic Ovary Syndrome in Rats – A Mini Review
Rakic, D., Jovic, N., Ilic, M. B., Dimitrijević, A., Djordjevic, O., Vulovic, T. S., Andrić, K., Jakovljevic, V. L., & Jović, J. J. (2021) · Serbian Journal of Experimental and Clinical Research · doi:10.2478/sjecr-2021-0034 · Cited by 1
Zhang, L., Li, G., Su, L., Du, L., Zhou, D., Cheng, X., Lin, Z., & Qu, S. (2021) · PubMed Central · doi:10.12122/j.issn.1673-4254.2021.12.04 · Cited by 2
Hayamizu, K., Kuramochi, Y., Sumino, A., Izumo, N., Furukawa, M., & Nakano, M. (2022) · Journal of Nutritional Health & Food Science · doi:10.15226/jnhfs.2022.001189 · Cited by 1
Polycystic ovary syndrome: ovarian pathophysiology and consequences after the menopause
Schmidt, J. G. H. (2011) · Gothenburg University Publications Electronic Archive (Gothenburg University) · Cited by 1
Conceptos básicos sobre infertilidad, incluido el síndrome de poliquistosis ovárica
Brassard, M., Ainmelk, Y., & Baillargeon, J. (2008) · Clínicas médicas de Norteamérica · doi:10.1016/s0186-0194(08)92058-x · Cited by 1
Síndrome del ovario poliquístico: nuevas perspectivas
Pazos, F., & Rodríguez-Caballero, A. (2004) · Endocrinología y Nutrición · doi:10.1016/s1575-0922(04)74657-4 · Cited by 1
Perfil hormonal e metabólico em pacientes hirsutas com a síndrome dos ovários policísticos
Poy, M., Wiltgen, D., & Spritzer, P. M. (2001) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302001000400007 · Cited by 1
THE GENETICS OF INSULIN RESISTANCE IN FAMILIES WITH POLYCYSTIC OVARY SYNDROME
Matar, J. (2006) · D-Scholarship@Pitt (University of Pittsburgh) · Cited by 1
Surgical Management Options for Patients with Infertility and Endometriosis
Catenacci, M., & Falcone, T. (2010) · Current Women s Health Reviews · doi:10.2174/157340410791321363 · Cited by 1
Isosexual Precocious Puberty and Polycystic Ovary Syndrome
Kumazaki, K., Kamoda, T., Ohto, T., Aoki, T., Shimakura, Y., Mesaki, N., Hirano, T., & Takita, H. (1996) · Clinical Pediatric Endocrinology · doi:10.1297/cpe.5.31 · Cited by 1
Adipositas und PCO-Syndrom bei jungen Mädchen
Wolf, A. (1998) · Der Gynäkologe · doi:10.1007/pl00003140 · Cited by 1
Störungen des Androgenhaushalts
Karck, U. (2005) · Springer eBooks · doi:10.1007/3-540-26406-x_16 · Cited by 1
Testosterone, SHBG, and the Metabolic Cardiovascular Syndrome
Zmuda, J. M., & Winters, S. J. (2004) · Humana Press eBooks · doi:10.1007/978-1-59259-727-7_17 · Cited by 1
Lifestyle Intervention in Polycystic Ovarian Syndrome
Janssen, O. E., Tan, S., & Hahn, S. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-310-3_28 · Cited by 1
Polycystic Ovary Syndrome, Obesity and Insulin Resistance
Cassar, S. (2014) · Victoria University Research Repository (Victoria University) · Cited by 1
Polycystic Ovary Syndrome and the Metabolic Syndrome
Janssen, O. E., Tan, S., Dietz, T., & Hahn, S. (2007) · CRC Press eBooks · doi:10.3109/9780849379581-37 · Cited by 1
Duran, J. M. (2019) · Digital Access to Scholarship at Harvard (DASH) (Harvard University) · Cited by 1
Avaliação do perfil de miRNAs circulantes em pacientes com síndrome dos ovários policísticos
Maffazioli, G. D. N. (2021) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2021.tde-16082021-130548 · Cited by 1
Metformin treatment before and during IVF/ICSI in women with polycystic ovarian syndrome
Tso, L. O., Costello, M., Albuquerque, L. E. T., Andriolo, R. B., & de Freitas, V. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006105 · Cited by 1
Epidemiology of pancreatic cancer : a global approach
Bosetti, C. (2014) · Research Publications (Maastricht University) · doi:10.26481/dis.20140903cb
Metformin for the Treatment of Polycystic Ovary Syndrome (PCOS)
Patel, S. S., Beshay, V. E., & Carr, B. R. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-392-3_2
Metabolic and ovarian consequences of perinatal sex steroid programming
Alexanderson, C. (2008) · Gothenburg University Publications Electronic Archive (Gothenburg University)
Diet and Endometrial Cancer : Insulin related factors
Friberg, E. (2009) · Figshare
Diabetes, physical activity and endometrial cancer
Friberg, E. (2006) · Figshare
A global approach to dissecting lipid-induced impairment of liver gluconeogenesis
Hayward, B. J. (2013)
Yen, S. S. C., Laughlin, G. A., & Morales, A. J. (1995) · Springer eBooks · doi:10.1007/978-1-4612-2518-8_17
Störungen des Androgenhaushalts
Weiss, J. M. (2009) · Springer eBooks · doi:10.1007/978-3-540-89760-6_16
Bedeutung der Insulinresistenz beim polyzystischen Ovarsyndrom – prä- und postkonzeptionell
Edimiris, P., Kimmig, R., & Köninger, A. (2015) · Der Gynäkologe · doi:10.1007/s00129-015-3788-7
Novye gorizonty primeneniya tiazolidindionov
Pigarova, E. A., & Dzeranova, L. K. (2006) · Obesity and metabolism · doi:10.14341/2071-8713-5139
Recommandations pour le diagnostic et le suivi du syndrome des ovaires polykystiques
Théron-Gérard, L., Cédrin‐Durnerin, I., & Hugues, J. (2008) · EMC - Gynécologie · doi:10.1016/s0246-1064(08)44358-x
Teixeira, R. J., Ginzbarg, D., Freitas, J. R., Fucks, G., da Silva, C. M., & Bordallo, M. A. N. (2003) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302003000300010
Metadata
- Authors
- NESTLER, J. E., POWERS, L. P., MATT, D. W., STEINGOLD, K. A., PLYMATE, S. R., RITTMASTER, R. S., CLORE, J. N., & BLACKARD, W. G.
- Affiliations
- Madigan Army Medical Center (US)
- ORCID
- PLYMATE, STEPHEN R.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1991-01
- Volume
- 72
- Issue
- 1
- Pages
- 83-89
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2008509267
- Cited by
- 815
- References
- 38
- Citations by year
- 2026: 13 · 2025: 22 · 2024: 25 · 2023: 25 · 2022: 28 · 2021: 38 · 2020: 27 · 2019: 25 · 2018: 18 · 2017: 25 · 2016: 25 · 2015: 30 · 2014: 22 · 2013: 27 · 2012: 18
- FWCI
- 10.34
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (DK-18904)
- National Center for Research Resources (RR 00065, M01RR000065)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- hyperinsulinemia, sex hormone-binding globulin, polycystic ovary syndrome, obesity, insulin resistance, diazoxide, leuprolide, GnRH agonist, testosterone, androstenedione, estradiol, estrone, glucose tolerance, insulin secretion, ovarian steroidogenesis, glucose-insulin interaction, insulin sensitivity index, insulin resistance index
- MeSH terms
- Adult, Androstenedione, Diazoxide, Estradiol, Estrone, Female, Glucose Tolerance Test, Humans, Insulin, Insulin Resistance, Gonadotropin-Releasing Hormone, Obesity, Polycystic Ovary Syndrome, Progesterone, Sex Hormone-Binding Globulin, Testosterone, Androstane-3,17-diol, Leuprolide
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review